Clinical Trials for Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)

Find clinical trials for metastatic hormone-sensitive prostate cancer (mhspc). Discover research opportunities and treatment options in your area.

5 Active Trials Found

Showing 5 trials on this page

Page 1 of 1

ProBio: A Biomarker Driven Study in Patients With Metastatic Prostate Cancer

NCT ID: NCT03903835

The ProBio trial is studying new treatment options for men with metastatic prostate cancer, which means the cancer has spread beyond the prostate to other parts of the body. This trial is looking a...

Recruiting

Phase: PHASE3 Type: interventional Locations: Kortrijk, , Belgium, Stockholm, , Sweden +36 more

Impact of Apalutamide in Metastatic Hormone Sensitive Prostate Cancer Patients

NCT ID: NCT06019676

The ADAPT study is looking at how well a medication called apalutamide works for men with metastatic hormone-sensitive prostate cancer, which means the cancer has spread but still responds to hormo...

Recruiting

Type: observational Locations: Sutton, Surrey, United Kingdom, Lancaster, , United Kingdom +12 more

Androgen Receptor Signaling and Prostate-Specific Membrane Antigen Expression

NCT ID: NCT05683964

This clinical trial is studying how early hormonal therapies can affect a specific marker, called Prostate-Specific Membrane Antigen (PSMA), in men with recurrent prostate cancer. Researchers want ...

Recruiting

Phase: EARLY_PHASE1 Type: interventional Locations: Boston, Massachusetts, United States

Multimodal Approach in Patients With mHSPC. Randomized Trial of APA+ADT vs APA-ADT and Local Treatment

NCT ID: NCT05649943

This clinical trial is studying a new treatment approach for men with metastatic hormone-sensitive prostate cancer (mHSPC), which is a form of prostate cancer that has spread but is still responsiv...

Recruiting

Phase: NA Type: interventional Locations: Milan, Mi, Italy, Milano, Lombardia, Italy +1 more

Comparing a 6-month vs Long-term Course of Rezvilutamide With ADT Plus Chemotherapy in mHSPC

NCT ID: NCT05956639

This clinical trial is studying two different treatment durations of a medication called Rezvilutamide, combined with hormone therapy and chemotherapy, for men with a specific type of prostate canc...

Recruiting

Phase: PHASE3 Type: interventional Locations: Nanjing, Jiangsu, China

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions